The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...

New research reveals that ER+ breast cancer cells acquire aggressive characteristics through direct contact with bone marrow ...

Fred Hutch grew from a regional cancer center into a world-class biomedical research and clinical care institution known for ...

Neutrophils are the most abundant white blood cells in the human body, primarily recognized for their essential roles in fighting infections and regulating inflammation.

The mainstay of treatment is surgery to remove the tumor, but you may also take chemotherapy and targeted therapies. Keep reading to learn more about the types of bone cancer, some of the ...

How Breast Cancer Cells Survive in Bone Marrow After Remission Dec. 4, 2024 — A new study has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells ...

"This high global demand is largely driven by the ongoing challenges posed by bone defects, particularly following trauma or surgical interventions such as tumor excision," said Dr. Whyte ...

A pioneering study has uncovered the complex and dual roles of neutrophils in cancer development, demonstrating their ...

Tests found that the surgeon did not have any signs of immune deficiency and the tumor was successfully removed from his hand. When it was tested, it was found that the tumor was a malignant fibrous ...

Tumor Infiltrating Lymphocytes (TIL) is under clinical development by Essen Biotech and currently in Phase II for Metastatic Breast Cancer.

like tumor necrosis factor-alpha, to facilitate the recruitment of mesenchymal stem cells (MSCs) and initiate the bone-regeneration process. This inflammation process begins immediately upon ...